Beyond the Peak: Managing GLP-1 Therapy at Maximum Dose
Reaching the maximum dose of GLP-1 agonists is not a treatment endpoint but a transition point requiring active maintenance strategies. Clinicians should shift focus from weight loss to preserving lean mass through protein-rich diets and resistance training. For patients who regain weight or face coverage barriers, options include tapering, switching medications, or considering minimally invasive surgery.